Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
May act as a protease inhibitor to modulate the host immune response against tumor cells.. Additionally we are shipping Squamous Cell Carcinoma Antigen 1 Kits (16) and Squamous Cell Carcinoma Antigen 1 Proteins (2) and many more products for this protein.
Showing 3 out of 3 products:
role of SERPINB3 (show SERPINB3 Antibodies)/B4 mutations in immunotherapy response
Data show that in colorectal cancer SerpinB3 (show SERPINB3 Antibodies), COX-2 (show COX2 Antibodies) and beta-Catenin (show CTNNB1 Antibodies) are positively correlated and associated with more advanced tumor stage.
Results showed no correlation between gestational age and vaginal fluid SCC (show CYP11A1 Antibodies) levels. There was no significant difference in vaginal fluid SCC (show CYP11A1 Antibodies) levels between patients with premature rupture of membranes and those with control pregnant women.
Serum SCC (show CYP11A1 Antibodies)-Ag level was an important predictor for the cervical squamous carcinoma recurrence and prognosis.
Data indicate that serum tumor markers showed significant shorter 3-year progression-free survival (PFS) in higher levels compared to lower levels for S-CYFRA 21-1 (cytokeratin 19 (show KRT19 Antibodies) fragment), S-SCCA and S-CEA (show CEACAM5 Antibodies).
SerpinB3 (show SERPINB3 Antibodies) indirectly increased the transcription of Myc (show MYC Antibodies) through the induction of Yap (show YAP1 Antibodies) pathway.
Data show that oropharyngeal squamous cell carcinomas (OPSCCs) express granzyme inhibitors SERPINB1 (show SERPINB1 Antibodies), SERPINB4 (show SERPINB4 Antibodies) and SERPINB9 (show SERPINB9 Antibodies) for cytotoxicity and the expression was not different between human papillomavirus (HPV)-positive and HPV-negative tumors.
Data show that serum neuron-specific enolase (show ENO2 Antibodies), cytokeratin 19 (show KRT19 Antibodies) fragment 21-1, pro-gastrin-releasing peptide (show GRP Antibodies), squamous cell carcinoma antigen, tissue inhibitor of metalloproteinase-1, and human epididymis protein 4 are not associated with brain metastases.
Pediatric CNS-PNETs evade immune recognition by downregulating cell surface MHC (show HLAE Antibodies)-I and CD1d (show CD1D Antibodies) expression. Intriguingly, expression of SERPINB9 (show SERPINB9 Antibodies), SERPINB1 (show SERPINB1 Antibodies), and SERPINB4 (show SERPINB4 Antibodies) is acquired during tumorigenesis in 29%, 29%, and 57% of the tumors
The diagnostic performance of SCCA-IgM immune complexes for hepatocellular carcinoma was found to be frequently superior to that of alpha-fetoprotein (show AFP Antibodies). (Review)
May act as a protease inhibitor to modulate the host immune response against tumor cells.
, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3
, serpin B3
, squamous cell carcinoma antigen 1
, SCCA2/SCCA1 fusion protein
, peptidase inhibitor 11
, protease inhibitor (leucine-serpin)
, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 4
, serpin B4
, squamous cell carcinoma antigen 2